"Surpass(ing)" an era of basal-bolus insulin therapy: tirzepatide vs insulin lispro tid added-on to poorly controlled basal insulin-treated type 2 diabetes

被引：0
|
作者：
Frias, J. P. [1 ]
Rosenstock, J. [2 ]
Rodbard, H. W. [3 ]
Tofe, S. [4 ]
Sears, E. [5 ]
Huh, R. [5 ]
Lando, L. Fernandez [5 ]
Patel, H. [5 ]
机构：
[1] Velocity Clin Res, Los Angeles, CA USA
[2] Velocity Clin Res Med City, Dallas, TX USA
[3] Endocrine & Metab Consultants, Rockville, MD USA
[4] Univ Hosp Son Espases, Palma De Mallorca, Spain
[5] Eli Lilly & Co, Indianapolis, IN 46285 USA
来源：
DIABETOLOGIA | 2023年 / 66卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
6
引用
收藏
页码：S5 / S6
页数：2
相关论文
共 50 条
  • [21] An economic assessment of analogue basal-bolus insulin versus human basal-bolus insulin in subjects with type 1 diabetes in the UK
    Palmer, Andrew J.
    Valentine, William J.
    Ray, Joshua A.
    Foos, Volker
    Lurati, Francesco
    Smith, Inger
    Lammert, Morten
    Roze, Stephane
    CURRENT MEDICAL RESEARCH AND OPINION, 2007, 23 (04) : 895 - 901
  • [22] Basal insulin glargine vs prandial insulin lispro in type 2 diabetes -: Reply
    Linn, Thomas
    Landgraf, W.
    Bretzel, Reinhard G.
    LANCET, 2008, 372 (9636): : 372 - 372
  • [23] Comparison of canagliflozin and liraglutide as a replacement for bolus insulin in type 2 diabetes patients well-controlled by basal-bolus insulin
    Kumashiro, N.
    Ando, Y.
    Shigiyama, F.
    Igarashi, H.
    Yoshikawa, F.
    Uchino, H.
    Yoshino, H.
    Miyagi, M.
    Ikehara, K.
    Hirose, T.
    DIABETOLOGIA, 2018, 61 : S126 - S126
  • [24] Prandial insulin substitution with insulin lispro or insulin lispro, mid mixture vs. basal therapy with insulin glargine:: A randomized controlled trial in patients with type 2 diabetes beginning insulin therapy
    Kazda, C
    Hülstrunk, H
    Helsberg, K
    Langer, F
    Forst, T
    Hanefeld, M
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2006, 20 (03) : 145 - 152
  • [25] Stepwise intensification of prandial insulin versus basal-bolus insulin therapy in patients with type 2 diabetes mellitus
    Raccah, D.
    Haak, T.
    Huet, D.
    Monnier, L.
    Ramon, J. S.
    Robertson, D.
    Labard, P.
    Penfornis, A.
    DIABETOLOGIA, 2010, 53
  • [26] Intensification of insulin therapy in patients with type 2 diabetes mellitus: An algorithm for basal-bolus therapy
    Abrahamson, Martin J.
    Peters, Anne
    ANNALS OF MEDICINE, 2012, 44 (08) : 836 - 846
  • [27] Efficacy and safety of insulin glulisine versus insulin lispro as part of a basal-bolus insulin regimen in children and adolescents with type I diabetes mellitus
    Philotheou, A.
    Arslanian, S.
    Blatniczky, L.
    Peterkova, V.
    Souhami, E.
    Danne, T.
    DIABETOLOGIA, 2008, 51 : S382 - S382
  • [28] THE COSTS OF INTENSIFICATION FROM BASAL INSULIN TO BASAL-BOLUS IN TYPE 2 DIABETES: A SURVEY OF PHYSICIANS
    Pfeiffer, K. M.
    Basse, A.
    Brod, M.
    VALUE IN HEALTH, 2018, 21 : S74 - S74
  • [29] Proportion and characteristics of patients with type 2 diabetes initiating basal insulin therapy with a basal-bolus regimen in China
    Zhang, Puhong
    Zhang, Heng
    Zhu, Dongshan
    Li, Xian
    Ji, Jiachao
    Zhao, Fang
    Lu, Juming
    Jia, Weiping
    Ji, Linong
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2018, 34
  • [30] Use of insulin degludec, a new basal insulin with an ultra-long duration of action, in basal-bolus therapy in type 1 and type 2 diabetes
    Kerlan, Veronique
    Gouet, Didier
    Marre, Michel
    Renard, Eric
    ANNALES D ENDOCRINOLOGIE, 2013, 74 (5-6) : 487 - 490
12345